Lung Cancer Diagnosis and Therapeutics Market Report

Global and Region Lung Cancer Diagnosis and Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：179
  • REPORT CODE：GMM952241
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Lung Cancer Diagnosis and Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Lung Cancer Diagnosis and Therapeuticsmarket, defines the market attractiveness level of Lung Cancer Diagnosis and Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Lung Cancer Diagnosis and Therapeutics industry, describes the types of Lung Cancer Diagnosis and Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lung Cancer Diagnosis and Therapeutics market and the development prospects and opportunities of Lung Cancer Diagnosis and Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lung Cancer Diagnosis and Therapeutics market in Chapter 13.

    By Player:

    • Eli Lilly

    • Eisai

    • GSK

    • Merck

    • Pfizer

    • Genentech

    • AbbVie

    • Novartis

    • Daiichi Sankyo

    • Sanofi

    • Bristol-Myers Squibb

    • Pharmacyclics

    • ArQule

    • Boehringer Ingelheim

    • Celgene

    • Roche

    • AstraZeneca

    • Bayer

    By Type:

    • Non-Small Cell Lung Cancer

    • Small Cell Lung Cancer

    By End-User:

    • Hospitals

    • Cancer Research Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Lung Cancer Diagnosis and Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Lung Cancer Diagnosis and Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Lung Cancer Diagnosis and Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Lung Cancer Diagnosis and Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Lung Cancer Diagnosis and Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Lung Cancer Diagnosis and Therapeutics Consumption (2017-2022)

    • 7.2 United States Lung Cancer Diagnosis and Therapeutics Consumption (2017-2022)

    • 7.3 Europe Lung Cancer Diagnosis and Therapeutics Consumption (2017-2022)

    • 7.4 China Lung Cancer Diagnosis and Therapeutics Consumption (2017-2022)

    • 7.5 Japan Lung Cancer Diagnosis and Therapeutics Consumption (2017-2022)

    • 7.6 India Lung Cancer Diagnosis and Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Lung Cancer Diagnosis and Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Lung Cancer Diagnosis and Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Lung Cancer Diagnosis and Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Lung Cancer Diagnosis and Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Lung Cancer Diagnosis and Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Lung Cancer Diagnosis and Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Lung Cancer Diagnosis and Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Lung Cancer Diagnosis and Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Lung Cancer Diagnosis and Therapeutics Consumption Forecast (2022-2028)

    9 Global Lung Cancer Diagnosis and Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Non-Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)

    • 9.2 Global Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Research Centers Consumption and Growth Rate (2017-2022)

    10 Global Lung Cancer Diagnosis and Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Non-Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Lung Cancer Diagnosis and Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Lung Cancer Diagnosis and Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Lung Cancer Diagnosis and Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Lung Cancer Diagnosis and Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Lung Cancer Diagnosis and Therapeutics Market Competitive Analysis

    • 14.1 Eli Lilly

      • 14.1.1 Eli Lilly Company Details

      • 14.1.2 Eli Lilly Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.2 Eisai

      • 14.2.1 Eisai Company Details

      • 14.2.2 Eisai Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Eisai Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.3 GSK

      • 14.3.1 GSK Company Details

      • 14.3.2 GSK Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GSK Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.4 Merck

      • 14.4.1 Merck Company Details

      • 14.4.2 Merck Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.5 Pfizer

      • 14.5.1 Pfizer Company Details

      • 14.5.2 Pfizer Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Pfizer Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.6 Genentech

      • 14.6.1 Genentech Company Details

      • 14.6.2 Genentech Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Genentech Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.7 AbbVie

      • 14.7.1 AbbVie Company Details

      • 14.7.2 AbbVie Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AbbVie Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.8 Novartis

      • 14.8.1 Novartis Company Details

      • 14.8.2 Novartis Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.9 Daiichi Sankyo

      • 14.9.1 Daiichi Sankyo Company Details

      • 14.9.2 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.10 Sanofi

      • 14.10.1 Sanofi Company Details

      • 14.10.2 Sanofi Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.11 Bristol-Myers Squibb

      • 14.11.1 Bristol-Myers Squibb Company Details

      • 14.11.2 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.12 Pharmacyclics

      • 14.12.1 Pharmacyclics Company Details

      • 14.12.2 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.13 ArQule

      • 14.13.1 ArQule Company Details

      • 14.13.2 ArQule Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 ArQule Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.14 Boehringer Ingelheim

      • 14.14.1 Boehringer Ingelheim Company Details

      • 14.14.2 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.15 Celgene

      • 14.15.1 Celgene Company Details

      • 14.15.2 Celgene Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Celgene Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.16 Roche

      • 14.16.1 Roche Company Details

      • 14.16.2 Roche Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Roche Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.17 AstraZeneca

      • 14.17.1 AstraZeneca Company Details

      • 14.17.2 AstraZeneca Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 AstraZeneca Lung Cancer Diagnosis and Therapeutics Product and Service

    • 14.18 Bayer

      • 14.18.1 Bayer Company Details

      • 14.18.2 Bayer Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Bayer Lung Cancer Diagnosis and Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Lung Cancer Diagnosis and Therapeutics

    • Figure Lung Cancer Diagnosis and Therapeutics Picture

    • Table Global Lung Cancer Diagnosis and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lung Cancer Diagnosis and Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Lung Cancer Diagnosis and Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Lung Cancer Diagnosis and Therapeutics Consumption by Country (2017-2022)

    • Figure United States Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Lung Cancer Diagnosis and Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Diagnosis and Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Lung Cancer Diagnosis and Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Research Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Research Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Lung Cancer Diagnosis and Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Lung Cancer Diagnosis and Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Genentech (Foundation Year, Company Profile and etc.)

    • Table Genentech Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Pharmacyclics (Foundation Year, Company Profile and etc.)

    • Table Pharmacyclics Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmacyclics Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table ArQule (Foundation Year, Company Profile and etc.)

    • Table ArQule Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table ArQule Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Lung Cancer Diagnosis and Therapeutics Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Lung Cancer Diagnosis and Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Lung Cancer Diagnosis and Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US